UniProt ID | SLAI2_HUMAN | |
---|---|---|
UniProt AC | Q9P270 | |
Protein Name | SLAIN motif-containing protein 2 | |
Gene Name | SLAIN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 581 | |
Subcellular Localization | Cytoplasm, cytoskeleton. Colocalizes with microtubules. Detected at the plus end of growing microtubules. | |
Protein Description | Binds to the plus end of microtubules and regulates microtubule dynamics and microtubule organization. Promotes cytoplasmic microtubule nucleation and elongation. Required for normal structure of the microtubule cytoskeleton during interphase.. | |
Protein Sequence | MEDVNSNVNADQEVRKLQELVKKLEKQNEQLRSRSGAVQGAGSLGPGSPVRAGASIPSSGAASPRGFPLGLSAKSGGGPGSGPRRTSSEELRDATSLLAAGEGGLLDEVEPLRPDELERLSGWEEEEESWLYSSPKKKLTPMQKSVSPLVWCRQVLDYPSPDVECAKKSLIHKLDQTMSALKRQNLYNNPFNSMSYTSPYSPNASSPYSSGFNSPSSTPVRPPIVKQLILPGNSGNLKSSDRNPPLSPQSSIDSELSASELDEDSIGSNYKLNDVTDVQILARMQEESLRQEYAATTSRRSSGSSCNSTRRGTFSDQELDAQSLDDEDDNMHHAVYPAVNRFSPSPRNSPRPSPKQSPRNSPRSRSPARGIEYSRVSPQPMISRLQQPRLSLQGHPTDLQTSNVKNEEKLRRSLPNLSRTSNTQVDSVKSSRSDSNFQVPNGGIPRMQPQASAIPSPGKFRSPAAPSPLALRQPVKAFSNHGSGSPGSQEITQLTQTTSSPGPPMVQSTVSANPPSNINSATLTRPAGTTAMRSGLPRPSAPSAGGIPVPRSKLAQPVRRSLPAPKTYGSMKDDSWKDGCY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEDVNSNV -------CCCHHHCC | 10.02 | 22814378 | |
33 | Phosphorylation | KQNEQLRSRSGAVQG HHHHHHHHCCCCCCC | 39.11 | 25627689 | |
35 | Phosphorylation | NEQLRSRSGAVQGAG HHHHHHCCCCCCCCC | 32.14 | 25159151 | |
43 | Phosphorylation | GAVQGAGSLGPGSPV CCCCCCCCCCCCCCC | 29.62 | 23927012 | |
48 | Phosphorylation | AGSLGPGSPVRAGAS CCCCCCCCCCCCCCC | 24.29 | 22167270 | |
51 | Methylation | LGPGSPVRAGASIPS CCCCCCCCCCCCCCC | 30.59 | 115389093 | |
55 | Phosphorylation | SPVRAGASIPSSGAA CCCCCCCCCCCCCCC | 33.83 | 23927012 | |
58 | Phosphorylation | RAGASIPSSGAASPR CCCCCCCCCCCCCCC | 39.47 | 23927012 | |
59 | O-linked_Glycosylation | AGASIPSSGAASPRG CCCCCCCCCCCCCCC | 27.39 | 30379171 | |
59 | Phosphorylation | AGASIPSSGAASPRG CCCCCCCCCCCCCCC | 27.39 | 25159151 | |
63 | O-linked_Glycosylation | IPSSGAASPRGFPLG CCCCCCCCCCCCCCC | 18.00 | 30379171 | |
63 | Phosphorylation | IPSSGAASPRGFPLG CCCCCCCCCCCCCCC | 18.00 | 30266825 | |
65 | Methylation | SSGAASPRGFPLGLS CCCCCCCCCCCCCCC | 57.81 | 115389101 | |
72 | Phosphorylation | RGFPLGLSAKSGGGP CCCCCCCCCCCCCCC | 31.67 | 25159151 | |
81 | Phosphorylation | KSGGGPGSGPRRTSS CCCCCCCCCCCCCCH | 49.08 | 29396449 | |
86 | Phosphorylation | PGSGPRRTSSEELRD CCCCCCCCCHHHHHH | 37.57 | 30266825 | |
87 | Phosphorylation | GSGPRRTSSEELRDA CCCCCCCCHHHHHHH | 33.66 | 27273156 | |
88 | Phosphorylation | SGPRRTSSEELRDAT CCCCCCCHHHHHHHH | 34.18 | 30266825 | |
95 | Phosphorylation | SEELRDATSLLAAGE HHHHHHHHHHHHHCC | 24.97 | 30108239 | |
96 | Phosphorylation | EELRDATSLLAAGEG HHHHHHHHHHHHCCC | 24.09 | 30108239 | |
132 | Phosphorylation | EEEESWLYSSPKKKL HHHHHHCCCCCCCCC | 10.80 | 22199227 | |
133 | Phosphorylation | EEESWLYSSPKKKLT HHHHHCCCCCCCCCC | 37.68 | 22199227 | |
134 | Phosphorylation | EESWLYSSPKKKLTP HHHHCCCCCCCCCCC | 27.47 | 25159151 | |
140 | Phosphorylation | SSPKKKLTPMQKSVS CCCCCCCCCCCCCCC | 26.12 | 28985074 | |
144 | Acetylation | KKLTPMQKSVSPLVW CCCCCCCCCCCHHHH | 46.72 | 7428257 | |
145 | Phosphorylation | KLTPMQKSVSPLVWC CCCCCCCCCCHHHHH | 15.78 | 30266825 | |
147 | Phosphorylation | TPMQKSVSPLVWCRQ CCCCCCCCHHHHHHH | 21.43 | 19664994 | |
158 | Phosphorylation | WCRQVLDYPSPDVEC HHHHHHCCCCCCHHH | 11.05 | 30266825 | |
160 | Phosphorylation | RQVLDYPSPDVECAK HHHHCCCCCCHHHHH | 27.74 | 30266825 | |
177 | Phosphorylation | LIHKLDQTMSALKRQ HHHHHHHHHHHHHHC | 16.86 | 25159151 | |
179 | Phosphorylation | HKLDQTMSALKRQNL HHHHHHHHHHHHCCC | 33.56 | 25159151 | |
182 | Methylation | DQTMSALKRQNLYNN HHHHHHHHHCCCCCC | 52.21 | 115981123 | |
182 | Ubiquitination | DQTMSALKRQNLYNN HHHHHHHHHCCCCCC | 52.21 | - | |
197 | Phosphorylation | PFNSMSYTSPYSPNA CCCCCCCCCCCCCCC | 18.87 | 28348404 | |
198 | Phosphorylation | FNSMSYTSPYSPNAS CCCCCCCCCCCCCCC | 17.38 | 28348404 | |
200 | Phosphorylation | SMSYTSPYSPNASSP CCCCCCCCCCCCCCC | 36.21 | 28348404 | |
201 | Phosphorylation | MSYTSPYSPNASSPY CCCCCCCCCCCCCCC | 18.30 | 23898821 | |
209 | Phosphorylation | PNASSPYSSGFNSPS CCCCCCCCCCCCCCC | 27.63 | 28348404 | |
210 | Phosphorylation | NASSPYSSGFNSPSS CCCCCCCCCCCCCCC | 41.37 | 28348404 | |
214 | Phosphorylation | PYSSGFNSPSSTPVR CCCCCCCCCCCCCCC | 24.73 | 28348404 | |
234 | Phosphorylation | QLILPGNSGNLKSSD EEECCCCCCCCCCCC | 34.67 | 25159151 | |
239 | Phosphorylation | GNSGNLKSSDRNPPL CCCCCCCCCCCCCCC | 40.41 | 30266825 | |
240 | Phosphorylation | NSGNLKSSDRNPPLS CCCCCCCCCCCCCCC | 38.72 | 30266825 | |
247 | Phosphorylation | SDRNPPLSPQSSIDS CCCCCCCCCCHHHCC | 27.02 | 30266825 | |
250 | Phosphorylation | NPPLSPQSSIDSELS CCCCCCCHHHCCCCC | 32.42 | 30266825 | |
251 | Phosphorylation | PPLSPQSSIDSELSA CCCCCCHHHCCCCCH | 25.76 | 30266825 | |
254 | Phosphorylation | SPQSSIDSELSASEL CCCHHHCCCCCHHHC | 38.47 | 30266825 | |
257 | Phosphorylation | SSIDSELSASELDED HHHCCCCCHHHCCCC | 26.20 | 30266825 | |
259 | Phosphorylation | IDSELSASELDEDSI HCCCCCHHHCCCCCC | 35.00 | 30266825 | |
265 | Phosphorylation | ASELDEDSIGSNYKL HHHCCCCCCCCCCCC | 27.14 | 30266825 | |
268 | Phosphorylation | LDEDSIGSNYKLNDV CCCCCCCCCCCCCCC | 35.00 | 28450419 | |
270 | Phosphorylation | EDSIGSNYKLNDVTD CCCCCCCCCCCCCCH | 20.67 | 28450419 | |
276 | Phosphorylation | NYKLNDVTDVQILAR CCCCCCCCHHHHHHH | 33.06 | 28555341 | |
288 | Phosphorylation | LARMQEESLRQEYAA HHHHHHHHHHHHHHH | 28.27 | 28796482 | |
293 | Phosphorylation | EESLRQEYAATTSRR HHHHHHHHHHHHCCC | 8.00 | 28796482 | |
296 | Phosphorylation | LRQEYAATTSRRSSG HHHHHHHHHCCCCCC | 19.68 | 28796482 | |
297 | Phosphorylation | RQEYAATTSRRSSGS HHHHHHHHCCCCCCC | 18.60 | 28796482 | |
298 | Phosphorylation | QEYAATTSRRSSGSS HHHHHHHCCCCCCCC | 22.72 | 28796482 | |
301 | Phosphorylation | AATTSRRSSGSSCNS HHHHCCCCCCCCCCC | 37.63 | - | |
302 | Phosphorylation | ATTSRRSSGSSCNST HHHCCCCCCCCCCCC | 40.66 | - | |
304 | Phosphorylation | TSRRSSGSSCNSTRR HCCCCCCCCCCCCCC | 33.40 | 30576142 | |
305 | Phosphorylation | SRRSSGSSCNSTRRG CCCCCCCCCCCCCCC | 22.35 | 30576142 | |
308 | Phosphorylation | SSGSSCNSTRRGTFS CCCCCCCCCCCCCCC | 27.84 | - | |
309 | Phosphorylation | SGSSCNSTRRGTFSD CCCCCCCCCCCCCCC | 15.47 | - | |
313 | Phosphorylation | CNSTRRGTFSDQELD CCCCCCCCCCCHHHC | 20.39 | 23401153 | |
315 | Phosphorylation | STRRGTFSDQELDAQ CCCCCCCCCHHHCCC | 37.92 | 23927012 | |
323 | Phosphorylation | DQELDAQSLDDEDDN CHHHCCCCCCCCCCC | 35.17 | 23927012 | |
336 | Phosphorylation | DNMHHAVYPAVNRFS CCHHHHHHHHHHCCC | 6.05 | 23927012 | |
343 | Phosphorylation | YPAVNRFSPSPRNSP HHHHHCCCCCCCCCC | 22.64 | 22167270 | |
345 | Phosphorylation | AVNRFSPSPRNSPRP HHHCCCCCCCCCCCC | 34.98 | 22167270 | |
349 | Phosphorylation | FSPSPRNSPRPSPKQ CCCCCCCCCCCCCCC | 24.46 | 30266825 | |
353 | Phosphorylation | PRNSPRPSPKQSPRN CCCCCCCCCCCCCCC | 46.11 | 30266825 | |
357 | Phosphorylation | PRPSPKQSPRNSPRS CCCCCCCCCCCCCCC | 31.77 | 22167270 | |
361 | Phosphorylation | PKQSPRNSPRSRSPA CCCCCCCCCCCCCCC | 23.99 | 23403867 | |
364 | Phosphorylation | SPRNSPRSRSPARGI CCCCCCCCCCCCCCC | 40.26 | 23403867 | |
366 | Phosphorylation | RNSPRSRSPARGIEY CCCCCCCCCCCCCCC | 24.94 | 30183078 | |
373 | Phosphorylation | SPARGIEYSRVSPQP CCCCCCCCCCCCCCC | 10.39 | 23927012 | |
374 | Phosphorylation | PARGIEYSRVSPQPM CCCCCCCCCCCCCCC | 17.26 | 23401153 | |
377 | Phosphorylation | GIEYSRVSPQPMISR CCCCCCCCCCCCHHH | 19.39 | 23401153 | |
383 | Phosphorylation | VSPQPMISRLQQPRL CCCCCCHHHHCCCCH | 22.23 | 23403867 | |
391 | Phosphorylation | RLQQPRLSLQGHPTD HHCCCCHHHCCCCCC | 21.67 | 25159151 | |
397 | Phosphorylation | LSLQGHPTDLQTSNV HHHCCCCCCHHCCCC | 43.60 | 23927012 | |
401 | Phosphorylation | GHPTDLQTSNVKNEE CCCCCHHCCCCCCHH | 29.57 | 23927012 | |
402 | Phosphorylation | HPTDLQTSNVKNEEK CCCCHHCCCCCCHHH | 27.02 | 23927012 | |
413 | Phosphorylation | NEEKLRRSLPNLSRT CHHHHHHHCCCCCCC | 41.57 | 22167270 | |
418 | Phosphorylation | RRSLPNLSRTSNTQV HHHCCCCCCCCCCCC | 39.90 | 23927012 | |
427 | Phosphorylation | TSNTQVDSVKSSRSD CCCCCCCCCCCCCCC | 32.37 | 28857561 | |
430 | Phosphorylation | TQVDSVKSSRSDSNF CCCCCCCCCCCCCCC | 28.91 | 23401153 | |
431 | Phosphorylation | QVDSVKSSRSDSNFQ CCCCCCCCCCCCCCC | 30.04 | 28450419 | |
433 | Phosphorylation | DSVKSSRSDSNFQVP CCCCCCCCCCCCCCC | 47.54 | 30266825 | |
435 | Phosphorylation | VKSSRSDSNFQVPNG CCCCCCCCCCCCCCC | 40.57 | 30266825 | |
452 | Phosphorylation | PRMQPQASAIPSPGK CCCCCCCCCCCCCCC | 22.83 | 30266825 | |
456 | Phosphorylation | PQASAIPSPGKFRSP CCCCCCCCCCCCCCC | 39.92 | 30266825 | |
459 | Acetylation | SAIPSPGKFRSPAAP CCCCCCCCCCCCCCC | 40.77 | 25953088 | |
462 | Phosphorylation | PSPGKFRSPAAPSPL CCCCCCCCCCCCCCC | 23.25 | 30266825 | |
467 | Phosphorylation | FRSPAAPSPLALRQP CCCCCCCCCCHHCCC | 28.02 | 30266825 | |
472 | Methylation | APSPLALRQPVKAFS CCCCCHHCCCCHHHC | 32.90 | 54559353 | |
534 | Phosphorylation | AGTTAMRSGLPRPSA CCCCHHHCCCCCCCC | 31.43 | 28555341 | |
538 | Methylation | AMRSGLPRPSAPSAG HHHCCCCCCCCCCCC | 42.73 | 58859569 | |
540 | Phosphorylation | RSGLPRPSAPSAGGI HCCCCCCCCCCCCCC | 54.83 | 27251275 | |
543 | Phosphorylation | LPRPSAPSAGGIPVP CCCCCCCCCCCCCCC | 38.98 | 28555341 | |
551 | Methylation | AGGIPVPRSKLAQPV CCCCCCCHHHCCCCH | 46.81 | 24129315 | |
553 | Methylation | GIPVPRSKLAQPVRR CCCCCHHHCCCCHHH | 49.47 | 24129315 | |
561 | Phosphorylation | LAQPVRRSLPAPKTY CCCCHHHCCCCCCCC | 28.30 | 24719451 | |
570 | Phosphorylation | PAPKTYGSMKDDSWK CCCCCCCCCCCCCCC | 16.55 | 27251275 | |
581 | Phosphorylation | DSWKDGCY------- CCCCCCCC------- | 27.41 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SLAI2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SLAI2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-48, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; SER-63 AND SER-433,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-48, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43; SER-48; SER-55;SER-63; SER-147; SER-179; SER-247; SER-250; SER-251; SER-254; SER-257;SER-315; SER-323; SER-377; SER-413; SER-456; SER-462 AND SER-467, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43; SER-48; SER-63;SER-147; SER-160; SER-234 AND SER-467, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-418, AND MASSSPECTROMETRY. |